GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Reyon Pharmaceutical Co Ltd (XKRX:102460) » Definitions » Other Long Term Assets

Reyon Pharmaceutical Co (XKRX:102460) Other Long Term Assets : ₩25,702 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Reyon Pharmaceutical Co Other Long Term Assets?

Reyon Pharmaceutical Co's other long-term assets for the quarter that ended in Sep. 2024 was ₩25,702 Mil.

Reyon Pharmaceutical Co's quarterly other long-term assets increased from Mar. 2024 (₩23,891 Mil) to Jun. 2024 (₩26,486 Mil) but then stayed the same from Jun. 2024 (₩26,486 Mil) to Sep. 2024 (₩25,702 Mil).

Reyon Pharmaceutical Co's annual other long-term assets increased from Dec. 2021 (₩27,791 Mil) to Dec. 2022 (₩30,913 Mil) but then declined from Dec. 2022 (₩30,913 Mil) to Dec. 2023 (₩27,428 Mil).

Reyon Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Reyon Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reyon Pharmaceutical Co Other Long Term Assets Chart

Reyon Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24,651.02 24,623.18 27,790.75 30,913.13 27,428.20

Reyon Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30,687.67 27,428.20 23,891.36 26,485.88 25,701.81

Reyon Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Reyon Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Reyon Pharmaceutical Co Ltd (XKRX:102460) » Definitions » Other Long Term Assets
Comparable Companies
XKRX:084110 XKRX:007570 XKRX:001630 XKRX:000020 XKRX:092040 XKRX:096760 XKRX:005500 XKRX:293480 XKRX:003060 XKRX:058820 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
416, Yeongdong-daero, 8th floor, Gangnam-gu, Seoul, KOR
Website
http://reyonpharm.co.kr
Reyon Pharmaceutical Co Ltd is a Korea-based pharmaceutical company. It is engaged in the manufacturing and distribution of specialty medicines and raw materials. The main business of the company has been divided into generic drugs, original drugs, and drug substances The key products include eye drops, injection, antibiotics, skeletal muscle relaxants, coagulation drugs, anti-inflammatory enzymes, and blood vessels dialectic drugs, among others.

Reyon Pharmaceutical Co Headlines

No Headlines